Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 114

Sort by

Sort Order Select

Journal Articles

The AHR: adaptive evolution or one-off?

Michael H. Kroll

Blood (2019) 134 (26): 2337–2338.

https://doi.org/10.1182/blood.2019003943

Published: 2019

Journal Articles

Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor–tissue factor axis

Mostafa Belghasem, Daniel Roth, Sean Richards, Marc Arthur Napolene, Joshua Walker, Wenqing Yin, Nkiruka Arinze, Chimera Lyle, Cheryl Spencer, Jean M. Francis, Cristal Thompson, Christopher Andry, Stephen A. Whelan, Norman Lee, Katya Ravid, Vipul C. Chitalia

Blood (2019) 134 (26): 2399–2413.

https://doi.org/10.1182/blood.2019001675

Published: 2019

Includes: Supplemental data

Journal Articles

The Ire of IRE1α: Overexpression of IRE1α at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1α Expression Is Predictive of Therapy Resistance

Scott R. Goldsmith, MD, Mark A. Fiala, BS, Mark A. Schroeder, MD, Tanya M. Wildes, MD, Armin Ghobadi, MD, Ravi Vij, MBBS, Keith E. Stockerl-Goldstein, MD

Blood (2019) 134 (Supplement_1): 4351.

https://doi.org/10.1182/blood-2019-131135

Published: 2019

Journal Articles

Analysis of Falls in Older Adults with Multiple Myeloma Undergoing First-Line Therapy

Kelly L. Schoenbeck, MD, Tanya M. Wildes, MD, Mark A. Fiala, BS

Blood (2019) 134 (Supplement_1): 5886.

https://doi.org/10.1182/blood-2019-129611

Published: 2019

Journal Articles

Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined Analysis of the STORM and Mammoth Studies

Blood (2019) 134 (Supplement_1): 3125.

https://doi.org/10.1182/blood-2019-124991

Published: 2019

Journal Articles

Heterogeneous Genetic Alterations and Novel Pathogenic Pathways in Relapsed DLBCL Revealed By Whole Exome Sequencing

Jiao Ma, PhD, Kui Nie, PhD, Giorgio Inghirami, MD, Kenneth Eng, B.S., Olivier Elemento, PhD, Rex Au-Yeung, Yajie Shen, BSA, Gopesh Srivastava, Jerald Gong, MD, Mina L Xu, MD, Leonard H.C. Tan, Wayne Tam, MD PhD

Blood (2019) 134 (Supplement_1): 2770.

https://doi.org/10.1182/blood-2019-125448

Published: 2019

Journal Articles

Patterns of Care and Predictors of Survival in Adolescents and Young Adults with Hodgkin Lymphoma: A Population-Based Study

Justine M. Kahn, MD MS, Fran Maguire, PhD MPH, Qian Li, MS, Elysia Alvarez, MD MPH, Theresa H.M. Keegan, PhD MS

Blood (2019) 134 (Supplement_1): 2191.

https://doi.org/10.1182/blood-2019-129301

Published: 2019

Journal Articles

Ex Vivo Expansion with E478 Increases the Rate of CRISPR-Mediated Homology Directed Repair of the Beta-Globin Gene in Human Hematopoietic Stem Cells By >10-Fold and Improves In Vivo Engraftment By >120-Fold

Kevin A. Goncalves, PhD, Megan D. Hoban, PhD, Sharon L. Hyzy, MS, Katia S. George, BA, Anthony E. Boitano, PhD, Michael P. Cooke, PhD

Blood (2019) 134 (Supplement_1): 4634.

https://doi.org/10.1182/blood-2019-131157

Published: 2019

Journal Articles

Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Units (CBUs) and Promotes Faster Neutrophil Recovery and Uniform Engraftment with Potentially Less Acute Graft-Vs-Host Disease (GVHD)

Heather Stefanski, MD PhD, Claudio G Brunstein, MD PhD, David H. McKenna, MD, Darin Sumstad, MLS, Jeffrey S. Miller, MD, Bruce R. Blazar, MD, Todd E. DeFor, MS, Anthony E. Boitano, PhD, Michael P. Cooke, PhD, Glen D. Raffel, MD PhD, John C. Davis, Jr., MD MPH, MS, John E. Wagner, MD

Blood (2019) 134 (Supplement_1): 804.

https://doi.org/10.1182/blood-2019-122329

Published: 2019

Journal Articles

The Characteristics, Treatment Patterns, and Outcomes of Older Adults with Multiple Myeloma

Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI, Mark A. Schroeder, MD, Armin Ghobadi, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MBBS

Blood (2018) 132 (Supplement 1): 4463.

https://doi.org/10.1182/blood-2018-99-118660

Published: 2018

Journal Articles

Metabolomics Profiling after Allogeneic Hematopoietic Stem Cell Transplantation Unravels a Specific Signature in Human Acute GVHD

David Michonneau, MD, Eleonora Latis, Laetitia Dubouchet, Regis Peffault De Latour, Marie Robin, MD PhD, Flore Sicre De Fontbrune, MD PhD, Lars Rogge, PhD, Gerard Socie, MD PhD

Blood (2018) 132 (Supplement 1): 69.

https://doi.org/10.1182/blood-2018-99-110441

Published: 2018

Journal Articles

Newly Identified Metabolites Connect Colon Cancer to Thrombosis

Mostafa Belghasem, MD PhD, Daniel Michael Roth, MSc, BSc, Joshua Aaron Walker, PhD, Sean Richards, Cheryl Spencer, Joseph Yeghishe Tashijan, BSc, Nkriuka Arinze, MD, Chris Andry, MPhil, PhD, Katya Ravid, PhD DSc, Vipul Chitalia, MD PhD

Blood (2018) 132 (Supplement 1): 78.

https://doi.org/10.1182/blood-2018-99-113680

Published: 2018

Journal Articles

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Relapsed/Refractory Acute Myeloid Leukemia

Muhammad Umair Mushtaq, MD, Sibgha Gull Chaudhary, MD, Guru Subramanian Guru Murthy, MBBS, Aric C. Hall, MD, Ehab L. Atallah, MD, Ryan J. Mattison, MD

Blood (2018) 132 (Supplement 1): 5246.

https://doi.org/10.1182/blood-2018-99-112204

Published: 2018

Journal Articles

Pre-Engraftment Gut Colonization with Enterococcus Casseliflavus Improves Survival after Allogeneic Hematopoietic Cell Transplantation

Armin Rashidi, MD PhD, Maryam Ebadi, MD, Robin Shields-Cutler, PhD, Todd E. DeFor, MS, Dan Knights, PhD, Daniel J. Weisdorf, MD

Blood (2018) 132 (Supplement 1): 813.

https://doi.org/10.1182/blood-2018-99-111630

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Myelodysplastic Syndrome in Adolescent and Young Adult Patients

Yoshimitsu Shimomura, MD, Masahiko Hara, Takaaki Konuma, MD PhD, Hidehiro Itonaga, MD, PhD, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Naoyuki Uchida, MD PhD, Takehiko Mori, MD PhD, Junji Tanaka, MD PhD, Takahiro Fukuda, MD PhD, Yoshiko Atsuta, MD PhD, Takayuki Ishikawa, Ken Ishiyama, MD PhD

Blood (2018) 132 (Supplement 1): 3452.

https://doi.org/10.1182/blood-2018-99-113275

Published: 2018

Journal Articles

Changing Incidence of Major Cardiovascular Events in Multiple Myeloma Patients over Time

Aaron Seth Rosenberg, MD, Qian Li, MS, Ann M Brunson, MS, Joseph Tuscano, MD, Ted Wun, MD, Theresa H.M. Keegan, PhD MS

Blood (2018) 132 (Supplement 1): 3598.

https://doi.org/10.1182/blood-2018-99-117959

Published: 2018

Journal Articles

Increased Risk of Diabetes Mellitus Among Adult Survivors of B-Cell Non-Hodgkin Lymphoma

Derek K Chang, MSPH, Jihye Park, RN, MSPH, Yuan Wan, MSCE, Alison Fraser, MSPH, Kerry Rowe, PhD, John Snyder, MS, Vikrant Deshmukh, PhD, Michael Newman, MS, Kimberly Herget, MS, Ken Smith, PhD, Mia Hashibe, PhD, Catherine J. Lee, MD

Blood (2018) 132 (Supplement 1): 4769.

https://doi.org/10.1182/blood-2018-99-120242

Published: 2018

Journal Articles

Aryl Hydrocarbon Receptor (AHR) Antagonism As a Transformative, Dual-Mechanism Novel Therapy for Multiple Myeloma

Taylor Gonzalez, Evan C Catton, Ashley E. Rosko, MD, Yvonne Efebera, MD, Maria Chaudhry, MD, Francesca Cottini, MD, Bethany L Mundy-Bosse, PhD, Tiffany Hughes, BS, PhD, Don M. Benson, Jr., MD PhD

Blood (2018) 132 (Supplement 1): 1933.

https://doi.org/10.1182/blood-2018-99-117465

Published: 2018

Journal Articles

Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function

Blood (2018) 132 (17): 1792–1804.

https://doi.org/10.1182/blood-2018-03-838474

Published: 2018

Includes: Supplemental data

Journal Articles

Effect of Autologous Hematopoietic Stem Cell Transplant (aHSCT) on the Development of Second Primary Malignancies (SPM) in Multiple Myeloma Patients

Aaron Seth Rosenberg, MD, Ann M Brunson, MS, Joseph M Tuscano, MD, Brian A Jonas, MD PhD, Mehrdad Abedi, MD, Ted Wun, MD FACP, FRCPA, Theresa H.M. Keegan, PhD MS

Blood (2017) 130 (Supplement 1): 332.

https://doi.org/10.1182/blood.V130.Suppl_1.332.332

Published: 2017

NARROW

The AHR: adaptive evolution or one-off?

Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor–tissue factor axis

The Ire of IRE1α: Overexpression of IRE1α at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1α Expression Is Predictive of Therapy Resistance

Analysis of Falls in Older Adults with Multiple Myeloma Undergoing First-Line Therapy

Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined Analysis of the STORM and Mammoth Studies

Heterogeneous Genetic Alterations and Novel Pathogenic Pathways in Relapsed DLBCL Revealed By Whole Exome Sequencing

Patterns of Care and Predictors of Survival in Adolescents and Young Adults with Hodgkin Lymphoma: A Population-Based Study

Ex Vivo Expansion with E478 Increases the Rate of CRISPR-Mediated Homology Directed Repair of the Beta-Globin Gene in Human Hematopoietic Stem Cells By >10-Fold and Improves In Vivo Engraftment By >120-Fold

Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Units (CBUs) and Promotes Faster Neutrophil Recovery and Uniform Engraftment with Potentially Less Acute Graft-Vs-Host Disease (GVHD)

The Characteristics, Treatment Patterns, and Outcomes of Older Adults with Multiple Myeloma

Metabolomics Profiling after Allogeneic Hematopoietic Stem Cell Transplantation Unravels a Specific Signature in Human Acute GVHD

Newly Identified Metabolites Connect Colon Cancer to Thrombosis

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Relapsed/Refractory Acute Myeloid Leukemia

Pre-Engraftment Gut Colonization with Enterococcus Casseliflavus Improves Survival after Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Myelodysplastic Syndrome in Adolescent and Young Adult Patients

Changing Incidence of Major Cardiovascular Events in Multiple Myeloma Patients over Time

Increased Risk of Diabetes Mellitus Among Adult Survivors of B-Cell Non-Hodgkin Lymphoma

Aryl Hydrocarbon Receptor (AHR) Antagonism As a Transformative, Dual-Mechanism Novel Therapy for Multiple Myeloma

Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function

Effect of Autologous Hematopoietic Stem Cell Transplant (aHSCT) on the Development of Second Primary Malignancies (SPM) in Multiple Myeloma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only